Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorYu Shi

About this trial

Patients who visited our hospital for various reasons from January 2024, underwent CT scans involving the pancreas, and were eligible for spectral post-processing reconstruction were included in the study. This research collected spectral CT data related to the pancreas at different phases, as well as physiological and pathological states for these patients. Quantitative analysis was conducted on post-processed data under different physiological and pathological states, including parameters such as pancreatic iodine uptake features, attenuation interval slopes, and extracellular volume size. In conjunction with general patient status, biochemical tests, and postoperative pathological results, the study aimed to identify correlations between parameters, develop models, and conduct research by comparing traditional CT data, which could be matched with spectral CT from the PACS database since its establishment.

Eligibility criteria

Qualifiers

None

Disqualifiers

Previous pancreatic surgery with incomplete pancreatic tissue.

Severe systemic diseases that result in severe organ dysfunction

Excessive pancreatic atrophy or other reasons cannot accurately delineate ROI

Trial design

Treatments tested in this trial

  • The post-processing generated after scanning is converted into energy spectrum image data (SBI)

Treatment groups

1,500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yu Shi

Lead sponsor

Shengjing Hospital

Sponsor institution